BioSpace News Archive

Business

RaySearch and C-RAD sign collaboration agreement

RaySearch Laboratories AB and C-RAD are pleased to announce a collaboration agreement, aiming at jointly developing innovative solutions and products to enhance the quality of radiation therapy.

May 4, 2024
·
2 min read
Pharm Country

UroGen Announces Results from ATLAS Showing Robust UGN-102 Durability of Response in New and Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer at AUA 2024

UroGen Pharma Ltd. announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier methods the probabilities of remaining in complete response for both new and recurrent low-grade intermediate-risk non- muscle invasive bladder cancer patients following treatment with investigational drug UGN-102 as primary therapy, with or without subsequent transurethral resection of the bladder tumor at 3 months.

May 4, 2024
·
9 min read
Pharm Country

New Real-World Study on Retrograde Instillation of JELMYTO® for Treatment of Low-Grade Upper Tract Urothelial Cancer Reports Similar Complete Response Rate and Lower Stricture Rate Compared to OLYMPUS Pivotal Trial

UroGen Pharma Ltd. highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO for pyelocalyceal solution presented at the American Urological Association Meeting 2024 in San Antonio, TX.

May 4, 2024
·
11 min read